Asymmetry Capital Management, L.P. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$10,152,000
+70.3%
229,117
+187.7%
6.10%
+97.9%
Q1 2021$5,962,000
-62.1%
79,650
-56.2%
3.08%
-57.0%
Q4 2020$15,715,000
+151.0%
181,650
+77.3%
7.17%
+78.0%
Q3 2020$6,262,000
-23.7%
102,462
-48.1%
4.02%
-35.9%
Q2 2020$8,202,000197,2496.28%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders